{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:56:47Z","timestamp":1790632607068,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UitZicht","award":["2014-27 PILOT"],"award-info":[{"award-number":["2014-27 PILOT"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00417-016-3417-8","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T15:26:33Z","timestamp":1467991593000},"page":"2033-2042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Central serous chorioretinopathy in primary hyperaldosteronism"],"prefix":"10.1007","volume":"254","author":[{"given":"Elon H. C.","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel F.","family":"Nijhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko K.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno C.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko P. J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel J. F.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"3417_CR1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","volume":"41","author":"G Liew","year":"2013","unstructured":"Liew G, Quin G, Gillies M, Fraser-Bell S (2013) Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 41:201\u2013214","journal-title":"Clin Exp Ophthalmol"},{"key":"3417_CR2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82\u2013118","journal-title":"Prog Retin Eye Res"},{"key":"3417_CR3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/eye.2010.130","volume":"24","author":"M Gemenetzi","year":"2010","unstructured":"Gemenetzi M, De Salvo G, Lotery AJ (2010) Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond) 24:1743\u20131756","journal-title":"Eye (Lond)"},{"key":"3417_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajo.2009.11.017","volume":"149","author":"LA Yannuzzi","year":"2010","unstructured":"Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149:361\u2013363","journal-title":"Am J Ophthalmol"},{"key":"3417_CR5","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","volume":"33","author":"DJ Warrow","year":"2013","unstructured":"Warrow DJ, Hoang QV, Freund KB (2013) Pachychoroid pigment epitheliopathy. Retina 33:1659\u20131672","journal-title":"Retina"},{"key":"3417_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"AS Kitzmann","year":"2008","unstructured":"Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002. Ophthalmology 115:169\u2013173","journal-title":"Ophthalmology"},{"key":"3417_CR7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/oxfordjournals.aje.a009326","volume":"146","author":"JM Zmuda","year":"1997","unstructured":"Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH (1997) Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 146:609\u2013617","journal-title":"Am J Epidemiol"},{"key":"3417_CR8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ophtha.2013.11.020","volume":"121","author":"A Miki","year":"2014","unstructured":"Miki A, Kondo N, Yanagisawa S, Bessho H, Honda S, Negi A (2014) Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. Ophthalmology 121:1067\u20131072","journal-title":"Ophthalmology"},{"key":"3417_CR9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.ophtha.2009.12.018","volume":"117","author":"LH Lima","year":"2010","unstructured":"Lima LH, Schubert C, Ferrara DC, Merriam JE, Imamura Y, Freund KB, Spaide RF, Yannuzzi LA, Allikmets R (2010) Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy. Ophthalmology 117:1567\u20131570","journal-title":"Ophthalmology"},{"key":"3417_CR10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ophtha.2014.09.026","volume":"122","author":"EK Jong de","year":"2015","unstructured":"de Jong EK, Breukink MB, Schellevis RL, Bakker B, Mohr JK, Fauser S, Keunen JE, Hoyng CB, den Hollander AI, Boon CJ (2015) Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. Ophthalmology 122:562\u2013570","journal-title":"Ophthalmology"},{"key":"3417_CR11","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","volume":"109","author":"CA Carvalho-Recchia","year":"2002","unstructured":"Carvalho-Recchia CA, Yannuzzi LA, Negrao S, Spaide RF, Freund KB, Rodriguez-Coleman H, Lenharo M, Iida T (2002) Corticosteroids and central serous chorioretinopathy. Ophthalmology 109:1834\u20131837","journal-title":"Ophthalmology"},{"key":"3417_CR12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/bjo.2004.054247","volume":"89","author":"JB Jonas","year":"2005","unstructured":"Jonas JB, Kamppeter BA (2005) Intravitreal triamcinolone acetonide and central serous chorioretinopathy. Br J Ophthalmol 89:386\u2013387","journal-title":"Br J Ophthalmol"},{"key":"3417_CR13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","volume":"111","author":"R Haimovici","year":"2004","unstructured":"Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S (2004) Risk factors for central serous chorioretinopathy: a case\u2013control study. Ophthalmology 111:244\u2013249","journal-title":"Ophthalmology"},{"key":"3417_CR14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archopht.1993.01090090081024","volume":"111","author":"EA Bouzas","year":"1993","unstructured":"Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, Kaiser-Kupfer MI (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111:1229\u20131233","journal-title":"Arch Ophthalmol"},{"key":"3417_CR15","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","volume":"122","author":"M Zhao","year":"2012","unstructured":"Zhao M, Celerier I, Bousquet E, Jeanny JC, Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F, Behar-Cohen F (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122:2672\u20132679","journal-title":"J Clin Invest"},{"key":"3417_CR16","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00417-014-2780-6","volume":"252","author":"TR Herold","year":"2014","unstructured":"Herold TR, Prause K, Wolf A, Mayer WJ, Ulbig MW (2014) Spironolactone in the treatment of central serous chorioretinopathy - a case series. Graefes Arch Clin Exp Ophthalmol 252:1985\u20131991","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3417_CR17","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","volume":"33","author":"E Bousquet","year":"2013","unstructured":"Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 33:2096\u20132102","journal-title":"Retina"},{"key":"3417_CR18","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1111\/aos.12392","volume":"92","author":"MB Breukink","year":"2014","unstructured":"Breukink MB, den Hollander AI, Keunen JE, Boon CJ, Hoyng CB (2014) The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy. Acta Ophthalmol 92:e488\u2013e490","journal-title":"Acta Ophthalmol"},{"key":"3417_CR19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/IAE.0000000000000748","volume":"36","author":"Q Ghadiali","year":"2016","unstructured":"Ghadiali Q, Jung JJ, Yu S, Patel SN, Yannuzzi LA (2016) Central serous chorioretinopathy treated with mineralocorticoid antagonists: a one-year pilot study. Retina 36:611\u2013618","journal-title":"Retina"},{"key":"3417_CR20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2147\/OPTH.S86778","volume":"9","author":"EK Chin","year":"2015","unstructured":"Chin EK, Almeida DR, Roybal CN, Niles PI, Gehrs KM, Sohn EH, Boldt HC, Russell SR, Folk JC (2015) Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy. Clin Ophthalmol 9:1449\u20131456","journal-title":"Clin Ophthalmol"},{"key":"3417_CR21","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000790","author":"EH Dijk van","year":"2016","unstructured":"van Dijk EH, Dijkman G, Biermasz NR, van Haalen FM, Pereira AM, Boon CJ (2016) Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome. Eur J Ophthalmol. doi: 10.5301\/ejo.5000790","journal-title":"Eur J Ophthalmol"},{"key":"3417_CR22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000310587","volume":"209","author":"S Daniele","year":"1995","unstructured":"Daniele S, Schepens CL, Daniele C, Angeletti G (1995) Fundus abnormalities in Cushing\u2019s disease: a preliminary report. Ophthalmologica 209:88\u201391","journal-title":"Ophthalmologica"},{"key":"3417_CR23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jcp.2007.053264","volume":"61","author":"B Rayner","year":"2008","unstructured":"Rayner B (2008) Primary aldosteronism and aldosterone-associated hypertension. J Clin Pathol 61:825\u2013831","journal-title":"J Clin Pathol"},{"key":"3417_CR24","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293\u20132300","journal-title":"J Am Coll Cardiol"},{"key":"3417_CR25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","volume":"147","author":"R Margolis","year":"2009","unstructured":"Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811\u2013815","journal-title":"Am J Ophthalmol"},{"key":"3417_CR26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3928\/15428877-20120426-02","volume":"43","author":"D Goldenberg","year":"2012","unstructured":"Goldenberg D, Moisseiev E, Goldstein M, Loewenstein A, Barak A (2012) Enhanced depth imaging optical coherence tomography: choroidal thickness and correlations with age, refractive error, and axial length. Ophthalmic Surg Lasers Imaging 43:296\u2013301","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"3417_CR27","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Y Imamura","year":"2009","unstructured":"Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29:1469\u20131473","journal-title":"Retina"},{"key":"3417_CR28","doi-asserted-by":"crossref","unstructured":"Chung YR, Kim JW, Kim SW, Lee K (2016) Choroidal thickness in patients with central serous chorioretinopathy: assessment of haller and sattler layers. Retina","DOI":"10.1097\/IAE.0000000000000998"},{"key":"3417_CR29","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1167\/iovs.12-10991","volume":"54","author":"L Yang","year":"2013","unstructured":"Yang L, Jonas JB, Wei W (2013) Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy. Invest Ophthalmol Vis Sci 54:4659\u20134665","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3417_CR30","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/IAE.0b013e318242b990","volume":"32","author":"Y Nishida","year":"2012","unstructured":"Nishida Y, Fujiwara T, Imamura Y, Lima LH, Kurosaka D, Spaide RF (2012) Choroidal thickness and visual acuity in highly myopic eyes. Retina 32:1229\u20131236","journal-title":"Retina"},{"key":"3417_CR31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","volume":"104","author":"JL Wilkinson-Berka","year":"2009","unstructured":"Wilkinson-Berka JL, Tan G, Jaworski K, Miller AG (2009) Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Circ Res 104:124\u2013133","journal-title":"Circ Res"},{"key":"3417_CR32","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","volume":"24","author":"M Zhao","year":"2010","unstructured":"Zhao M, Valamanesh F, Celerier I, Savoldelli M, Jonet L, Jeanny JC, Jaisser F, Farman N, Behar-Cohen F (2010) The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells. FASEB J 24:3405\u20133415","journal-title":"FASEB J"},{"key":"3417_CR33","first-page":"221","volume":"8","author":"N Golestaneh","year":"2002","unstructured":"Golestaneh N, Picaud S, Mirshahi M (2002) The mineralocorticoid receptor in rodent retina: ontogeny and molecular identity. Mol Vis 8:221\u2013225","journal-title":"Mol Vis"},{"key":"3417_CR34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL (2013) Vascular actions of aldosterone. J Vasc Res 50:89\u201399","journal-title":"J Vasc Res"},{"key":"3417_CR35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","volume":"350","author":"A McCurley","year":"2012","unstructured":"McCurley A, Jaffe IZ (2012) Mineralocorticoid receptors in vascular function and disease. Mol Cell Endocrinol 350:256\u2013265","journal-title":"Mol Cell Endocrinol"},{"key":"3417_CR36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","volume":"93","author":"K Chapman","year":"2013","unstructured":"Chapman K, Holmes M, Seckl J (2013) 11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev 93:1139\u20131206","journal-title":"Physiol Rev"},{"key":"3417_CR37","doi-asserted-by":"crossref","first-page":"e1004474","DOI":"10.1371\/journal.pgen.1004474","volume":"10","author":"JL Bolton","year":"2014","unstructured":"Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA, Anderson A, Huffman J, Wilson JF, Campbell H, Rudan I, Wright A, Hastie N, Wild SH, Velders FP, Hofman A, Uitterlinden AG, Lahti J, Raikkonen K, Kajantie E, Widen E, Palotie A, Eriksson JG, Kaakinen M, Jarvelin MR, Timpson NJ, Davey Smith G, Ring SM, Evans DM, St Pourcain B, Tanaka T, Milaneschi Y, Bandinelli S, Ferrucci L, van der Harst P, Rosmalen JG, Bakker SJ, Verweij N, Dullaart RP, Mahajan A, Lindgren CM, Morris A, Lind L, Ingelsson E, Anderson LN, Pennell CE, Lye SJ, Matthews SG, Eriksson J, Mellstrom D, Ohlsson C, Price JF, Strachan MW, Reynolds RM, Tiemeier H, Walker BR (2014) Genome wide association identifies common variants at the SERPINA6\/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin. PLoS Genet 10:e1004474","journal-title":"PLoS Genet"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3417-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:05:12Z","timestamp":1498327512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3417-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3417"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3417-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]}}}